ArticleMicrobiology resource announcements2024
Two
Sarah Bouzidi, Julien Puech, Marta Fulla, Xavier González-Compta, Hélène Pere, Laia Alemany, David Veyer, Ignacio G Bravo
Open access · diamondAbstract read
In one paragraphArticle in Microbiology resource announcements, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 95% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed, 0 citations in OpenAlex.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
8 authors at 4 institutions in 2 countries.
Sarah BouzidiLaboratory MIVEGEC (Univ Montpellier CNRS, IRD), French National Center for Scientific Research (CNRS), Montpellier, France.
Julien PuechLaboratoire de Virologie, Service de Microbiologie, hôpital européen Georges Pompidou, Assistance Publique-Hôpitaux de Paris, Paris, France.
Marta FullaOtorhinolaryngology Department, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain.
Xavier González-ComptaOtorhinolaryngology Department, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain.
Hélène PereLaboratoire de Virologie, Service de Microbiologie, hôpital européen Georges Pompidou, Assistance Publique-Hôpitaux de Paris, Paris, France.
Laia AlemanyUnit of Molecular Epidemiology and Genetics (UNIC EMG), Cancer Epidemiology Research Program, Catalan Institute of Oncology, ICO, L'Hospitalet, Barcelona, Spain.
David VeyerLaboratoire de Virologie, Service de Microbiologie, hôpital européen Georges Pompidou, Assistance Publique-Hôpitaux de Paris, Paris, France.
Ignacio G BravoLaboratory MIVEGEC (Univ Montpellier CNRS, IRD), French National Center for Scientific Research (CNRS), Montpellier, France.ORCID 0000-0003-3389-3389 Inserm · FRBellvitge University Hospital · ESCentre National de la Recherche Scientifique · FRInstitut d'Investigació Biomédica de Bellvitge · ES
Funding
EC | H2020 | PRIORITY 'Excellent science' | H2020 European Research Council (ERC) ERC-2014-CoG- 647916
6 · The paper itselfAbstract
We communicate here two complete
Indexed as
HPVHPV11infection and cancerinverted sinonasal papillomapapillomavirus
Identifiers
PMID38441980
PMCPMC11008159
OpenAlexW4392454117
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390